Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: A meta-analysis (Q38459877)

3 September 2017

0 references

Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: A meta-analysis (English)

1 reference

3 September 2017

0 references

1 reference

1 reference

Lei Cao

1

1 reference

3 September 2017

Lei Wang

2

1 reference

3 September 2017

Lijia Yang

3

1 reference

3 September 2017

Shiqin Tao

4

1 reference

3 September 2017

Rushan Xia

5

1 reference

3 September 2017

Weixin Fan

6

1 reference

3 September 2017

5 May 2015

1 reference

Journal of Dermatological Treatment

3 September 2017

1 reference

3 September 2017

26

1 reference

3 September 2017

6

1 reference

3 September 2017

537-540

1 reference

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

3 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Cost of atopic dermatitis and eczema in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Atopic dermatitis and the hygiene hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Probiotics in primary prevention of allergic disease--follow-up at 8-9 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

A systematic review of the importance of milk TGF-β on immunological outcomes in the infant and young child

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2015.1027168

10.3109/09546634.2015.1027168

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference